| World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis M Lazo-Porras, GJ Prutsky, P Barrionuevo, JC Tapia, C Ugarte-Gil, ... BMC infectious diseases 20, 1-14, 2020 | 42 | 2020 |
| Hair follicle characteristics as early marker of type 2 diabetes JJ Miranda, A Taype-Rondan, JC Tapia, MG Gastanadui-Gonzalez, ... Medical hypotheses 95, 39-44, 2016 | 20 | 2016 |
| Weaknesses in the reporting of cross-sectional studies according to the STROBE statement: the case of metabolic syndrome in adults from Peru JC Tapia, EF Ruiz, OJ Ponce, G Malaga, J Miranda Colombia Médica 46 (4), 168-175, 2015 | 19 | 2015 |
| Associations with definitive outcomes and clinical benefit of cancer drugs at the time of marketing approval and in the postmarketing period A Bujosa, C Moltó, TJ Hwang, JC Tapia, KN Vokinger, AJ Templeton, ... Journal of the National Comprehensive Cancer Network 19 (13), 117-125, 2021 | 7 | 2021 |
| Aplicación de pruebas rápidas para el diagnóstico de sífilis en zonas rurales R Calderon-Anyosa, OJ Ponce, JC Tapia-Tapia, PJ García Revista Peruana de Medicina Experimental y Salud Pública 29 (1), 160-161, 2012 | 7 | 2012 |
| ¿ Por qué debemos regular el uso de prendas y uniformes de los profesionales de la salud? JC Tapia-Tapia, OJ Ponce, G Málaga Revista Medica Herediana 25 (3), 178-180, 2014 | 5 | 2014 |
| Dermatological journals available to Latin American dermatologists. JC Tapia, LA Diaz, F Bravo International Journal of Dermatology 54 (11), 2015 | 4 | 2015 |
| Treatment satisfaction and need for shared decision‐making in patients with psoriasis from Peru JC Tapia, K Chavez, G Malaga, F Bravo British Journal of Dermatology, 2017 | 3 | 2017 |
| 1585MO Factors associated with change in overall survival and quality of life between time of approval and post-marketing among anti-cancer therapies AB Rodríguez, CM Valiente, JC Tapia, I Gich, A Barnadas, E Amir, ... Annals of Oncology 31, S961-S962, 2020 | 2 | 2020 |
| The dream of health information for all A Proaño, EF Ruiz, R Porudominsky, JC Tapia F1000Research 5, 2016 | 2 | 2016 |
| 1719P Clinical characteristics and 28-day mortality among patients with solid cancers and COVID-19 in a tertiary hospital JC Tapia, J Gavira, M Riudavets, OJ Ponce, I Gich, A Barnadas, M Majem Annals of Oncology 31, S1010, 2020 | 1 | 2020 |
| Change in magnitude of clinical benefit, overall survival (OS) and quality of life (QoL) between time of approval and post-marketing among cancer drugs approved by the US Food … AB Rodríguez, JC Tapia, T Hwang, CM Valiente, AJ Templeton, ... Annals of Oncology 30, v671, 2019 | 1 | 2019 |
| Soil-transmitted helminth infections in South America OJ Ponce, JC Tapia-Tapia, G Malaga The Lancet Infectious Diseases 14 (3), 184, 2014 | 1 | 2014 |
| Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study F Massari, M Santoni, H Takeshita, Y Okada, JC Tapia, U Basso, ... Cancer Immunology, Immunotherapy 73 (6), 1-13, 2024 | | 2024 |
| NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors M Young, JC Tapia, B Szabados, A Jovaisaite, F Jackson-Spence, E Nally, ... Clinical Genitourinary Cancer 22 (3), 102072, 2024 | | 2024 |
| Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center … JC Tapia, F Bosma, J Gavira, S Sanchez, MA Molina, J Sanz-Beltran, ... Clinical Genitourinary Cancer 22 (3), 102047, 2024 | | 2024 |
| Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution J Gavira, JC Tapia, A Romano, G Anguera, M Aguado, A Piedra, F Bosma, ... Clinical and Translational Oncology, 1-5, 2024 | | 2024 |
| Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre … JC Tapia, J Gavira, G Anguera, S Sanchez, A Romano, F Bosma, ... Clinical and Translational Oncology, 1-6, 2024 | | 2024 |
| Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from … M Santoni, F Massari, H Takeshita, JC Tapia, M Dionese, R Pichler, ... Clinical and Experimental Medicine 23 (8), 5413-5422, 2023 | | 2023 |
| RETRACTED: Metastatic Prostate cancer (mPCa) and Homologous Recombination Deficiency (HRD) in daily practice: experience of 6 years in a tertiary hospital. J Gavira, JC Tapia, A Romano, G Anguera, M Aguado, A Piedra, F Bosma, ... European Urology Open Science 57, S188-S190, 2023 | | 2023 |
German MalagaProfessor, Universidad Peruana Cayetano HerediaVerified email at upch.pe
